comments last updated: August 8, 2024
In the WeedsDocument ID FDA-2023-E-3201-0006
Federal Register ID 2024-17511
Docket ID FDA-2023-E-3201
Want to get even more in the weeds?
Explore supplementary materials on regulations.govThe Food and Drug Administration FDA or the Agency has determined the regulatory review period for REZLIDHIA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office USPTO Department of Commerce for the extension of a patent which claims that human drug product.